You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Case Report: Convalescent Plasma Achieves SARS-CoV-2 Viral Clearance in a Patient With Persistently High Viral Replication Over 8 Weeks Due to Severe Combined Immunodeficiency (SCID) and Graft Failure
|
|---|---|
| Published in |
Frontiers in immunology, May 2021
|
| DOI | 10.3389/fimmu.2021.645989 |
| Pubmed ID | |
| Authors |
Verena Keitel, Johannes Georg Bode, Torsten Feldt, Andreas Walker, Lisa Müller, Anselm Kunstein, Caroline Klindt, Alexander Killer, Tina Senff, Jörg Timm, Philipp Ostermann, Maximilian Damagnez, Nadine Lübke, Ortwin Adams, Heiner Schaal, Gerald Antoch, Jennifer Neubert, Philipp Albrecht, Sven Meuth, Saskia Elben, Annemarie Mohring, Johannes C. Fischer, Edwin Bölke, Manfred Hoenig, Ansgar S. Schulz, Tom Luedde, Björn Jensen |
X Demographics
The data shown below were collected from the profiles of 39 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 7 | 18% |
| Brazil | 1 | 3% |
| India | 1 | 3% |
| United Kingdom | 1 | 3% |
| Turkey | 1 | 3% |
| Sweden | 1 | 3% |
| Germany | 1 | 3% |
| Comoros | 1 | 3% |
| South Africa | 1 | 3% |
| Other | 2 | 5% |
| Unknown | 22 | 56% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 33 | 85% |
| Practitioners (doctors, other healthcare professionals) | 4 | 10% |
| Scientists | 2 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 33 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 4 | 12% |
| Student > Master | 3 | 9% |
| Researcher | 3 | 9% |
| Student > Doctoral Student | 2 | 6% |
| Other | 2 | 6% |
| Other | 5 | 15% |
| Unknown | 14 | 42% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 6 | 18% |
| Nursing and Health Professions | 2 | 6% |
| Biochemistry, Genetics and Molecular Biology | 2 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
| Chemical Engineering | 1 | 3% |
| Other | 4 | 12% |
| Unknown | 17 | 52% |
Attention Score in Context
This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 January 2022.
All research outputs
#1,598,938
of 25,387,668 outputs
Outputs from Frontiers in immunology
#1,425
of 31,541 outputs
Outputs of similar age
#41,846
of 453,654 outputs
Outputs of similar age from Frontiers in immunology
#67
of 1,346 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 31,541 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 453,654 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 1,346 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.